Boston Scientific has recently reported the results of the Optical Coherence Tomography Drug Eluting Stent Investigation (OCTDESI)trial; part of the JACTAX stent program. [30] The JACTAX stent con ...

Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform ...

did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise ...

The use of drug-eluting stents (DES) has become widespread as a result of their superior revascularization rates compared with those of bare-metal stents (BMS). 1 DES are increasingly being used ...

The team from Doylestown Health's Vascular Surgery is the first in the greater Philadelphia region to use the Abbott ...

Polymer-free stents show comparable PCI results but with increased early thrombosis risk, impacting clinical choices.

A well-known example is the drug-eluting stent: originally stents were passive objects that kept blood vessels and other structures in the body, such as the trachea, open. In the late 1990s ...

The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...

The stent is left permanently in the artery to provide a reinforced channel through which blood can flow. Some stents (drug-eluting stents) are coated with medication that helps prevent the formation ...

India’s coronary stent market is projected to reach USD 1,213.5 million by 2033, growing at a CAGR of 3.7%. The increasing ...